Ipca Laboratories Ltd.

1195.80 -6.00 ▼-0.5%

05 March 2024, 10:28:59 AM
Volume: 17,038

Company Profile

Sector Healthcare Sector Icon Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Industry Icon Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.ipca.com
Market Cap 30,469.88 Cr.
Enterprise Value(EV) 31,924.11 Cr. 2023-09
Financial Indicators
Earnings per share (EPS) 22.24 Trailing Twelve Months Ending 2023-12
Price-Earning Ratio (PE) 54.00 Trailing Twelve Months Ending 2023-12
Industry PE 41.59 Trailing Twelve Months Ending 2023-12
Book Value / Share 251.13 Trailing Twelve Months Ending 2023-12
Price to Book Value 4.78 Calculated using Price: 1,201.00
Dividend Yield 0.33 Period Ending 2023-03
No. of Shares Subscribed 25.37 Cr. 253,704,218 Shares
FaceValue 1
About Ipca Laboratories Ltd.
Ipca Laboratories is engaged in manufacturing of active pharmaceutical ingredients and formulations. Ipca Laboratories is one of the largest suppliers of these APIs worldwide with manufacturing leadership in many APIs globally. It has various APIs and formulations manufacturing facility across the globe. The company has leading brands in Pain, Rheumatology, Antimalarials and Hair care therapy in India

Ipca Laboratories Ltd. Delivery

Delivered Qty
Traded Qty

Ipca Laboratories Ltd. Performance

1 Day
-0.50%
1 Week
-1.54%
1 Month
+7.85%
3 Month
+4.66%
6 Month
+36.36%
1 Year
+49.29%
2 Year
+25.25%
5 Year
+180.85%
10 Year
+167.61%

Ipca Laboratories Ltd. Fundamental Ratios

9 years 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03 2023-03
Return on Equity (%) 12.43 4.31 8.25 9.31 15.22 17.92 27.63 17.92 8.7
Return on Capital Employed (%) 13.78 4.82 9.18 9.81 16.48 19.71 30.92 20.46 11.71
Return on Assets (%) 7.38 2.5 4.96 5.93 10.21 12.31 20.29 13.31 6.06

Ipca Laboratories Ltd. Balance Sheet

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-09* Rs. Cr.
Shh. Funds 2,208 2,259 2,455 2,689 3,122 3,627 4,702 5,465 5,842 6,149
Non Curr. Liab. 700 663 548 419 313 290 190 614 902 1,127
Curr. Liab. 904 970 956 1,008 1,098 1,326 1,161 1,466 1,806 2,686
Minority Int. 16 14 15 77 73 1,412
Equity & Liab. 3,812 3,892 3,960 4,116 4,549 5,258 6,066 7,622 8,623 11,374
Non Curr. Assets 2,198 2,270 2,218 2,170 2,171 2,402 2,629 3,164 3,434 5,655
Curr. Assets 1,614 1,622 1,742 1,945 2,378 2,856 3,437 4,447 5,189 5,720
Misc. Exp. not W/O
Total Assets 3,812 3,892 3,960 4,116 4,549 5,258 6,066 7,622 8,623 11,374

Ipca Laboratories Ltd. Profit and Loss

Particulars 10 years 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr. 2023-12 Rs. Cr. TTM
Net Sales 3,144 2,867 3,156 3,258 3,746 4,619 5,395 5,797 6,204 7,186
Other Income 59 41 55 58 75 87 129 122 152 142
Total Income 3,203 2,908 3,211 3,316 3,820 4,706 5,524 5,918 6,356 7,328
Total Expenditure -2,630 -2,593 -2,741 -2,816 -3,067 -3,729 -3,914 -4,539 -5,301 -6,045
PBIDT 573 314 470 500 753 977 1,610 1,379 1,055 1,284
Interest -32 -35 -27 -28 -22 -20 -12 -11 -48 -127
Depreciation -180 -163 -173 -178 -182 -211 -209 -232 -262 -329
Taxation -102 -20 -68 -51 -104 -135 -240 -225 -253 -288
Exceptional Items 68
PAT 259 96 195 239 442 604 1,149 911 492 607
Minority Interest 3 3 -1 -6 -8 -35
Share Associate -5 -3 -8 -21 -13 -8
Other Related Items
Consolidated Net Profit 254 93 195 239 446 606 1,140 884 471 564
Adjusted EPS 10 4 8 9 18 24 45 35 19 22

Ipca Laboratories Ltd. Cash Flow

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2023-03 Rs. Cr.
Cash Fr. Operatn. 522 468 709 282 341 501 570 1,090 856 806
Cash Fr. Inv. -369 -689 -218 -149 -135 -165 -510 -521 -855 -725
Cash Fr. Finan. -136 251 -462 -159 -130 -183 -137 -306 427 507
Net Change 17 29 29 -26 75 153 -76 264 428 588
Cash & Cash Eqvt 74 104 169 143 218 371 295 559 991 1,579

Ipca Laboratories Ltd. Shareholding Pattern

9 Qtrs 2021-12 (%) 2022-03 (%) 2022-06 (%) 2022-09 (%) 2022-12 (%) 2023-03 (%) 2023-06 (%) 2023-09 (%) 2023-12 (%)
Promoter 46.29 46.29 46.29 46.29 46.29 46.29 46.29 46.29 46.29
Public 53.71 53.71 53.71 53.71 53.71 53.71 53.70 53.71 53.71
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Ipca Laboratories Ltd. Announcements

Tue, 27 Feb 2024
Copy of Newspaper Publication
IPCA Laboratories Limited has informed the Exchange about Copy of Newspaper Publication
Tue, 27 Feb 2024
Shareholders meeting
IPCA Laboratories Limited has informed the Exchange regarding Notice of Postal Ballot - Electronic Dispatch of Postal Ballot Notice to shareholders of the Company
Fri, 23 Feb 2024
Notice Of Shareholders Meetings-XBRL
Ipca Laboratories Limited has informed the Exchange about Notice of Shareholders Meeting for Postal Ballot

Ipca Laboratories Ltd. Technical Scans

Mon, 04 Mar 2024
Close Within 52 Week High Zone Close Within 52 Week High Zone
Making Higher Highs for 2 Days Making Higher Highs for 2 Days
High Increase in 1 Month High Increase in 1 Month
High Increase in 6 Months High Increase in 6 Months
High Increase in 1 Year High Increase in 1 Year

Ipca Laboratories Ltd. Related Stocks

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 372,436.77 1,548.00 -0.3%
Cipla Ltd. 118,783.64 1,466.55 -0.3%
Dr. Reddy's Laboratories Ltd. 105,691.98 6,302.95 -0.5%
Zydus Lifesciences Ltd. 95,764.63 942.70 -0.4%
Divi's Laboratories Ltd. 92,421.56 3,467.75 -0.4%
Torrent Pharmaceuticals Ltd. 91,038.44 2,689.45 0.0%
Apollo Hospitals Enterprise Ltd. 86,787.70 6,027.85 -0.1%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 41.82 1,548.00 -0.3%
Cipla Ltd. Consolidated 2023-12 32.03 1,466.55 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 20.22 6,302.95 -0.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 32.20 942.70 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 66.83 3,467.75 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 60.94 2,689.45 0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 109.95 6,027.85 -0.1%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-12 5.97 1,548.00 -0.3%
Cipla Ltd. Consolidated 2023-12 4.59 1,466.55 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-12 3.93 6,302.95 -0.5%
Zydus Lifesciences Ltd. Consolidated 2023-12 4.93 942.70 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-12 7.09 3,467.75 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-12 12.73 2,689.45 0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-12 12.85 6,027.85 -0.1%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 0.11 1,548.00 -0.3%
Cipla Ltd. Consolidated 2023-03 0.02 1,466.55 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 0.06 6,302.95 -0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 0.07 942.70 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 0.00 3,467.75 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 0.85 2,689.45 0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 0.44 6,027.85 -0.1%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,548.00 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,466.55 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,302.95 -0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 942.70 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,467.75 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,689.45 0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,027.85 -0.1%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 16.46 1,548.00 -0.3%
Cipla Ltd. Consolidated 2023-03 12.85 1,466.55 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 21.36 6,302.95 -0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 11.60 942.70 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 14.89 3,467.75 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 20.50 2,689.45 0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 15.16 6,027.85 -0.1%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 43,885.68 1,548.00 -0.3%
Cipla Ltd. Consolidated 2023-03 22,753.12 1,466.55 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 24,669.70 6,302.95 -0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 17,237.40 942.70 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 7,767.51 3,467.75 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 9,620.15 2,689.45 0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 16,612.50 6,027.85 -0.1%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2023-03 8,560.84 1,548.00 -0.3%
Cipla Ltd. Consolidated 2023-03 2,835.49 1,466.55 -0.3%
Dr. Reddy's Laboratories Ltd. Consolidated 2023-03 4,507.30 6,302.95 -0.5%
Zydus Lifesciences Ltd. Consolidated 2023-03 2,001.90 942.70 -0.4%
Divi's Laboratories Ltd. Consolidated 2023-03 1,823.38 3,467.75 -0.4%
Torrent Pharmaceuticals Ltd. Consolidated 2023-03 1,245.23 2,689.45 0.0%
Apollo Hospitals Enterprise Ltd. Consolidated 2023-03 887.50 6,027.85 -0.1%

Ipca Laboratories Ltd. FAQ's

What is Ipca Laboratories share price?

Can I buy Ipca Laboratories shares now?

What is the Dividend Yield of Ipca Laboratories?

What is the Market Cap of Ipca Laboratories?

What are the key metrics to analyse Ipca Laboratories?

What is the 52 Week High and Low of Ipca Laboratories?

What is the trend of Ipca Laboratories share price?